ArticleEmerging infectious diseases2026
Wickerhamomyces anomalus Fungemia during Healthcare-Associated Outbreak, Pereira, Colombia, 2025.
Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During March-July 2025, ten cases of Wickerhamomyces anomalus bloodstream infection were identified in Pereira, Colombia, mainly affecting pediatric patients; 9 cases occurred in children (8 neonates and a 5-year-old girl) and 1 case was in an adult. Most neonates were preterm and had multiple underlying conditions, such as congenital anomalies, respiratory complications, and adverse perinatal conditions, often compounded by limited prenatal care and maternal infections. All patients required intensive medical interventions, including central and peripheral venous catheters, mechanical ventilation, parenteral nutrition, and, in some cases, surgical procedures. Broad-spectrum antibacterial therapy was widely used, and antifungal treatment, primarily caspofungin, was initiated in half of cases. Antifungal susceptibility testing demonstrated low MICs for all agents. Short tandem repeat genotyping of 6 isolates indicated clonal transmission, supporting a healthcare-associated outbreak. Despite prolonged hospitalizations and severe clinical conditions, all patients survived, highlighting the importance of prompt diagnosis, strict infection control, and appropriate antifungal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.